Exciting New Vitamin D Research

Vitamin D research continues to be done to investigate its effect on various health concerns. Recent studies exploring whether vitamin D increases cancer survival and remission rates show that it has a significant influence as a chemoprotective agent. Since there are so many types of cancer and it is so prevalent, additional methods of fighting cancer are encouraging. Additionally, research shows positive impacts that vitamin D has on depression.  Adding vitamin D to a person’s daily routine can be done easily with supplements. Cloud vitamin cream offers an effective, simple-to-use topical vitamin D cream that provides an RDA’s worth of vitamin D3.

Investigating whether vitamin D improves depression has been met with exciting results. An article titled, “Effects of vitamin D supplementation on symptoms of depression in overweight and obese subjects:  randomized double blind trial” discussed a study that examined whether the supplementation of vitamin D had an impact on participants who were depressed, as well as being overweight or obese. The article stated that, “After 1 year, the subjects given 40,000 (DD group) or 20,000 (DP group) IU vitamin D per week had a significant improvement with BDI scores.” The article added that, “It is noteworthy that there was an improvement in BDI scores after vitamin D supplementation both in those with lower and higher baseline 25(OH)D levels.” The article explains that, “Depressed mood was judged with the Beck Depression Inventory (BDI) at inclusion and at the end of the study. BDI is a self-compiled questionnaire of 21 items in multiple choice format.” Therefore, improved BDI scores in the participants that increased their vitamin D intake clearly indicates that vitamin D has the ability to improve overall mood and alleviate depression.

Positive results have also been found that illustrate that vitamin D helps patients fighting cancer. A recent issue of The Journal of Clinical and Endocrinology and Metabolism reported that, “Researchers have again found that higher levels of circulating vitamin D on diagnosis of cancer are associated with significantly better survival and remission rates. The new findings come from a comprehensive meta-analysis involving more than 17,000 cancer patients.” This is promising news, since taking a vitamin D supplement is much easier and more tolerable than other types of cancer treatments. 

The meta-analysis also exhibited reductions in mortality for specific types of cancer. For example, overall survival of study participants with high circulating levels of vitamin D showed a 45% reduction in colorectal cancer, a 37% reduction in breast cancer and a 52% reduction in lymphoma. Additionally, the higher levels of vitamin D also had favorable effects for patients with lung cancer, gastric cancer, prostate cancer, leukemia, melanoma and Merkel cell carcinoma. In a recent publication of Medscape Medical News, Hui Wang, MD, PhD, asserted that, “researchers tend to consider vitamin D as a cancer chemoprotective agent.” Dr. Wang went on to explain that, “A lot of laboratory studies have suggested that vitamin D might inhibit the progression of cancers by acting on tumor cells and modulating the tumor microenvironment.” This is significant because adding vitamin D to a patient’s daily care routine is simple, affordable and has no side effects. 

Not only are studies showing that vitamin D has a positive effect on depression and overall mood, but research also proves that vitamin D is able to help prevent cancer and reduce the progression of cancerous tumors. With this in mind, adding a dose of vitamin D every day is an easy and effective way to inhibit and reduce the advancement of many types of cancer. Applied topically to wet skin once daily, Cloud’s vitamin D cream is a safe and reliable method of ensuring healthy levels of vitamin D in the body.  

Articles cited:

  • “Effects of vitamin D supplementation on symptoms of depression in overweight and obese subjects:  randomized double blind trial” by R. Jorde, M Sneve, Y. Figenschau, J. Svartberg, and K. Waterloo, Journal of Internal Medicine
  • Medscape Medical News
  • The Journal of Clinical and Endocrinology and Metabolism
November 11, 2014 by Cathy Mohr
previous / next